The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Therapeutics And Biotherapeutics-Global Market Insights and Sales Trends 2024
Synopsis
The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.
The global Cancer Therapeutics And Biotherapeutics market size is expected to reach US$ 11780 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Therapeutics And Biotherapeutics in various end use industries. The expanding demands from the Consumption, Household and Hospital,, are propelling Cancer Therapeutics And Biotherapeutics market. Chemotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
The increasing occurrence of different types of cancer and the increasing proliferation of new players in this market are expected to boost the development of global cancer therapeutics and biotherapeutics market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Therapeutics And Biotherapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Therapeutics And Biotherapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Therapeutics And Biotherapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Therapeutics And Biotherapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Therapeutics And Biotherapeutics covered in this report include Bristol-Myers Squibb, AstraZeneca, Pfizer, Biogen IDEC, Sanofi, Genentech, Novartis, Johnson & Johnson and Roche and Schering-Plough, etc.
The global Cancer Therapeutics And Biotherapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
AstraZeneca
Pfizer
Biogen IDEC
Sanofi
Genentech
Novartis
Johnson & Johnson
Roche and Schering-Plough
Global Cancer Therapeutics And Biotherapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Therapeutics And Biotherapeutics market, Segment by Type:
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Global Cancer Therapeutics And Biotherapeutics market, by Application
Consumption
Household
Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Therapeutics And Biotherapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.
The global Cancer Therapeutics And Biotherapeutics market size is expected to reach US$ 11780 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Therapeutics And Biotherapeutics in various end use industries. The expanding demands from the Consumption, Household and Hospital,, are propelling Cancer Therapeutics And Biotherapeutics market. Chemotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
The increasing occurrence of different types of cancer and the increasing proliferation of new players in this market are expected to boost the development of global cancer therapeutics and biotherapeutics market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Therapeutics And Biotherapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Therapeutics And Biotherapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Therapeutics And Biotherapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Therapeutics And Biotherapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Therapeutics And Biotherapeutics covered in this report include Bristol-Myers Squibb, AstraZeneca, Pfizer, Biogen IDEC, Sanofi, Genentech, Novartis, Johnson & Johnson and Roche and Schering-Plough, etc.
The global Cancer Therapeutics And Biotherapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
AstraZeneca
Pfizer
Biogen IDEC
Sanofi
Genentech
Novartis
Johnson & Johnson
Roche and Schering-Plough
Global Cancer Therapeutics And Biotherapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Therapeutics And Biotherapeutics market, Segment by Type:
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Global Cancer Therapeutics And Biotherapeutics market, by Application
Consumption
Household
Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Therapeutics And Biotherapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Therapeutics And Biotherapeutics
1.1 Cancer Therapeutics And Biotherapeutics Market Overview
1.1.1 Cancer Therapeutics And Biotherapeutics Product Scope
1.1.2 Cancer Therapeutics And Biotherapeutics Market Status and Outlook
1.2 Global Cancer Therapeutics And Biotherapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Therapeutics And Biotherapeutics Market Size by Region (2018-2029)
1.4 Global Cancer Therapeutics And Biotherapeutics Historic Market Size by Region (2018-2023)
1.5 Global Cancer Therapeutics And Biotherapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Therapeutics And Biotherapeutics Market Size (2018-2029)
1.6.1 North America Cancer Therapeutics And Biotherapeutics Market Size (2018-2029)
1.6.2 Europe Cancer Therapeutics And Biotherapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size (2018-2029)
1.6.4 Latin America Cancer Therapeutics And Biotherapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size (2018-2029)
2 Cancer Therapeutics And Biotherapeutics Market by Type
2.1 Introduction
2.1.1 Chemotherapy
2.1.2 Radiation Therapy
2.1.3 Hormone Therapy
2.1.4 Biotherapy
2.2 Global Cancer Therapeutics And Biotherapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Therapeutics And Biotherapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Type (2018-2029)
3 Cancer Therapeutics And Biotherapeutics Market Overview by Application
3.1 Introduction
3.1.1 Consumption
3.1.2 Household
3.1.3 Hospital
3.2 Global Cancer Therapeutics And Biotherapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Therapeutics And Biotherapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue Breakdown by Application (2018-2029)
4 Cancer Therapeutics And Biotherapeutics Competition Analysis by Players
4.1 Global Cancer Therapeutics And Biotherapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Therapeutics And Biotherapeutics as of 2022)
4.3 Date of Key Players Enter into Cancer Therapeutics And Biotherapeutics Market
4.4 Global Top Players Cancer Therapeutics And Biotherapeutics Headquarters and Area Served
4.5 Key Players Cancer Therapeutics And Biotherapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Therapeutics And Biotherapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bristol-Myers Squibb
5.1.1 Bristol-Myers Squibb Profile
5.1.2 Bristol-Myers Squibb Main Business
5.1.3 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.1.4 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Bristol-Myers Squibb Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.2.4 AstraZeneca Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.3.4 Pfizer Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Biogen IDEC Recent Developments
5.4 Biogen IDEC
5.4.1 Biogen IDEC Profile
5.4.2 Biogen IDEC Main Business
5.4.3 Biogen IDEC Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.4.4 Biogen IDEC Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Biogen IDEC Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.5.4 Sanofi Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Genentech
5.6.1 Genentech Profile
5.6.2 Genentech Main Business
5.6.3 Genentech Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.6.4 Genentech Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Genentech Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.7.4 Novartis Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.8.4 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 Roche and Schering-Plough
5.9.1 Roche and Schering-Plough Profile
5.9.2 Roche and Schering-Plough Main Business
5.9.3 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Products, Services and Solutions
5.9.4 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Roche and Schering-Plough Recent Developments
6 North America
6.1 North America Cancer Therapeutics And Biotherapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Therapeutics And Biotherapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Therapeutics And Biotherapeutics Market Dynamics
11.1 Cancer Therapeutics And Biotherapeutics Industry Trends
11.2 Cancer Therapeutics And Biotherapeutics Market Drivers
11.3 Cancer Therapeutics And Biotherapeutics Market Challenges
11.4 Cancer Therapeutics And Biotherapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
